Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sparx Therapeutics

Request full access

Former Eli Lilly veteran Dr. Victor Wroblewski joins Sparx Therapeutics as a Senior VP and Head of Biology

Mount Prospect, United StatesFounded 2018Health

About Sparx Therapeutics

Sparx Bio is a biotechnology company specializing in the development of advanced pharmaceutical innovations aimed at treating cancer and central nervous system (CNS) diseases. Utilizing cutting-edge technologies such as Big Data Aided Target Mining, Antibody Phage Display, and Hybridoma Antibody Discovery, Sparx Bio has built a robust pipeline of therapeutic candidates. The company’s proprietary platforms, LEMMAb™ and SMARTOP™, focus on creating bispecific and multispecific antibodies that are more soluble, less prone to aggregation, and easier to purify. These antibodies are designed to enhance the efficacy and safety of treatments by minimizing mismatches and optimizing yield. Additionally, Sparx Bio employs the SPARX MULCOM™ nanotechnology platform to deliver multiple drugs and biologics simultaneously, improving the effectiveness of combination therapies. Sparx Bio primarily serves pharmaceutical companies and research institutions, operating in the highly specialized market of biopharmaceuticals. The company generates revenue through partnerships, licensing agreements, and the sale of its proprietary technologies and therapeutic candidates.

Source: Dealroom company data

Sparx Therapeutics in the Mount Prospect ecosystem

Live from Dealroom

The Sparx Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Sangel Capital
  • Highlight Capital
  • Rotating Boulder Fund
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States80%
🇨🇳 China20%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sparx Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sparx Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.